Clinical Trials Browser

NETWORK × Lymphoma × temsirolimus × Clear all

NCT02343718 2023-08-04

Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

Phase 1 Completed

Lymphoma